Publications

Home » Publications
Export 7 results:
Filters: Keyword is Child Mortality  [Clear All Filters]
2024
Arzika AM, Abdou A, Maliki R, Beido N, Kadri B, Harouna AN, Galo AN, Alio MK, Lebas E, Oldenburg CE et al..  2024.  Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).. PLoS Med. 21(5):e1004386.
2020
Doan T, Worden L, Hinterwirth A, Arzika AM, Maliki R, Abdou A, Zhong L, Chen C, Cook C, Lebas E et al..  2020.  Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution.. N Engl J Med. 383(20):1941-1950.
Hinterwirth A, Sie A, Coulibaly B, Ouermi L, Dah C, Tapsoba C, Zhong L, Chen C, Lietman TM, Keenan JD et al..  2020.  Rapid Reduction of Species in the Gut Microbiome of Preschool Children after Oral Azithromycin: A Randomized Controlled Trial.. Am J Trop Med Hyg. 103(3):1266-1269.
2019
Sie A, Ouattara M, Bountogo M, Bagagnan C, Coulibaly B, Boudo V, Lebas E, Brogdon JM, Lin Y, Bärnighausen T et al..  2019.  A double-masked placebo-controlled trial of azithromycin to prevent child mortality in Burkina Faso, West Africa: Community Health with Azithromycin Trial (CHAT) study protocol.. Trials. 20(1):675.
Keenan JD, Arzika AM, Maliki R, Boubacar N, Adamou SElh, Ali MMoussa, Cook C, Lebas E, Lin Y, Ray KJ et al..  2019.  Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.. N Engl J Med. 380(23):2207-2214.
Lietman TM, Doan T, Keenan JD.  2019.  Macrolide Resistance and Longer-Term Assessment of Azithromycin in MORDOR I. Reply.. N Engl J Med. 381(22):2184-2185.
2018
Keenan JD, Bailey RL, West SK, Arzika AM, Hart J, Weaver J, Kalua K, Mrango Z, Ray KJ, Cook C et al..  2018.  Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.. N Engl J Med. 378(17):1583-1592.